About
Long Waypoint 81 publishes Sable Fathom — an independent resource on ibogaine and OCD evidence. We exist to separate careful description from hopeful speculation and to make research-accessible without offering clinical advice.
Our editorial approach
Sable Fathom focuses on evidence synthesis, methodological clarity, and safety context. We explain how studies were conducted, what outcomes were measured, and where uncertainty remains. For example, when describing clinical findings we reference original trial registries and peer-reviewed reports rather than repeating secondary summaries; this mirrors guidance used in evidence synthesis and is consistent with standards such as those summarized on the systematic review entry at Wikipedia.
How we source information
We draw on primary literature, clinical trial registries, regulatory advisories, and established institutional summaries. When a claim rests on case reports or preliminary work we label it clearly; when it is supported by replicated, controlled studies we state that plainly. Our vetting includes cross-checking trial identifiers and, where relevant, consulting authoritative public health pages such as NIH for context about research processes.
What we cover
Content is organized into concise briefs, explanatory pages, and safety summaries that highlight evidence strength and uncertainty. Pages commonly include: study descriptions, measured outcomes, safety signals, and links to original sources. We also maintain a collection of firsthand experiential reports to show how published evidence and personal experience can differ; one such repository we reference for perspectives is embedded in community archives like the ibogaine trip report collection at an ibogaine trip report archive which we cite strictly as experiential context rather than clinical evidence.
Who this is for
The site is intended for people living with OCD, their supporters, and professionals seeking a careful explanation of available research. We aim to make study design, outcome measures, and safety considerations clearer so readers can interpret claims and ask informed questions of clinicians or researchers.
Editorial principles
Our work follows a small set of principles intended to keep clarity and safety central.
- Evidence before claims — we privilege primary studies and transparent methodology.
- Clear uncertainty — we label hypotheses, indirect findings, and established evidence.
- Safety awareness — discussions include known risks and gaps in safety data.
- Plain language — technical findings are translated without oversimplifying limitations.
- Independence — we remain free of clinical affiliations and do not offer treatment.
Independent by design
Sable Fathom is an independent information resource produced by Long Waypoint 81. We are not a clinic, medical provider, or licensed treatment center, and our content is not medical or legal advice. For readers seeking clinical care, consult a licensed professional. Our footer restates this disclosure.
If you arrived here from another page in this site, you can return to the main landing material by following the site’s index; for example the site's homepage provides the top-level navigation and entry points to briefs and safety pages at the root index (see the site index available at the main directory through the site index). We also maintain an experiential-context link collection and community archives for contextual perspective; one archive often referenced for firsthand accounts is available at a community trip report archive.
To support verification of our editorial methods, we use registries and institutional resources where possible — trial registries and university repositories help confirm study design and registration dates; for general principles about study registration see clinical trial registration guidance on Wikipedia, and for federal research context consult the National Institutes of Health at nih.gov.
Questions about scope or sourcing?
If you want to understand how we select sources or propose clarifications, see our services page which describes how we support evidence summaries and editorial reviews for interested organizations and collaborators. We do not provide individualized treatment recommendations.